Cargando…

Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application

Human γδ T cells show potent cytotoxicity against various types of cancer cells in a major histocompatibility complex unrestricted manner. Phosphoantigens and nitrogen-containing bisphosphonates (N-bis) stimulate γδ T cells via interaction between the γδ T cell receptor (TCR) and butyrophilin subfam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyashita, Masatsugu, Shimizu, Teruki, Ashihara, Eishi, Ukimura, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396358/ https://www.ncbi.nlm.nih.gov/pubmed/34445615 http://dx.doi.org/10.3390/ijms22168910

Ejemplares similares

Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy
por: Lee, Derek, et al.
Publicado: (2022)

Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
por: Xing, Rui, et al.
Publicado: (2021)

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015)

Biological characteristics of γδT cells and application in tumor immunotherapy
por: Zhu, Renhong, et al.
Publicado: (2023)

γδ T Cells and Their Potential for Immunotherapy
por: Wu, Yan-Ling, et al.
Publicado: (2014)

γδ T cells in cancer immunotherapy
por: Zou, Chang, et al.
Publicado: (2016)

γδ T cell costimulatory ligands in antitumor immunity
por: McGraw, Joseph M., et al.
Publicado: (2022)

JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy
por: McGraw, Joseph M., et al.
Publicado: (2021)

γδ T Cell Immunotherapy—A Review
por: Kobayashi, Hirohito, et al.
Publicado: (2015)

Double renal cell carcinoma with histological type of clear cell carcinoma and papillary carcinoma in the same kidney concurrently treated with robot‐assisted partial nephrectomy
por: Shimizu, Teruki, et al.
Publicado: (2021)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

γδ T cells in immunotherapies for B-cell malignancies
por: Rimailho, Léa, et al.
Publicado: (2023)

γδ T Cells: The Ideal Tool for Cancer Immunotherapy
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2020)

3D modelling of γδ T‐cell immunotherapy
por: Hull, Caroline M., et al.
Publicado: (2022)

The emerging role of γδ T cells in cancer immunotherapy
por: Nussbaumer, Oliver, et al.
Publicado: (2019)

γδ T cells for cancer immunotherapy: A systematic review of clinical trials
por: Fisher, Jonathan PH, et al.
Publicado: (2014)

Treatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study
por: Inoue, Yuta, et al.
Publicado: (2023)

Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
por: Burnham, Rebecca E., et al.
Publicado: (2020)

γδ T cells and their clinical application in colon cancer
por: Corsale, Anna Maria, et al.
Publicado: (2023)

Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
por: Scheper, Wouter, et al.
Publicado: (2013)

Immunotherapy of acute myeloid leukemia based on γδ T cells
por: Gertner-Dardenne, Julie, et al.
Publicado: (2012)

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)

Current Advances in γδ T Cell-Based Tumor Immunotherapy
por: Lo Presti, Elena, et al.
Publicado: (2017)

Γδ T Cell-Based Immunotherapy in Melanoma: State of the Art
por: Toia, F., et al.
Publicado: (2019)

γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
por: Barros, Mateus de Souza, et al.
Publicado: (2021)

A close look at current γδ T-cell immunotherapy
por: Ma, Ling, et al.
Publicado: (2023)

γδ T cells: origin and fate, subsets, diseases and immunotherapy
por: Hu, Yi, et al.
Publicado: (2023)

Possibility of γδ T cell immunotherapy for HTLV-1-infected individuals
por: Sato, Tomoo, et al.
Publicado: (2011)

Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy
por: Khan, Mohd Wajid A., et al.
Publicado: (2014)

Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

3D models for melanoma γδ T cell‐based immunotherapy
por: Huber, Veronica, et al.
Publicado: (2022)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

Local γδ T cells: translating promise to practice in cancer immunotherapy
por: Zlatareva, Iva, et al.
Publicado: (2023)

Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy
por: Tarannum, Mubin, et al.
Publicado: (2022)

Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies
por: Meringa, A. D., et al.
Publicado: (2023)

Bone marrow metastasis in a patient with non‐seminomatous testicular germ cell tumor
por: Ueda, Takashi, et al.
Publicado: (2022)

Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
por: Song, Yuan, et al.
Publicado: (2022)

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
por: de Vries, Natasja L., et al.
Publicado: (2023)

RNA interference against polo-like kinase-1 in advanced non-small cell lung cancers
por: Kawata, Eri, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1pqtn8u24ut4acvo8ffjoqkell